Related Experiment Video
Updated: Jun 3, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Complement and glomerular disease: new insights
Matthew Pickering1, H Terence Cook
1Centre for Complement & Inflammation Research, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Insights
Complement dysregulation is linked to glomerular diseases like C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS). C5 inhibition shows promise for aHUS, but its role in C3 glomerulopathies requires further study.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- Complement dysregulation is closely associated with glomerular pathology.
- C3 glomerulopathy, including dense deposit disease (DDD) and CFHR5 nephropathy, is characterized by isolated C3 deposition.
- Atypical hemolytic uremic syndrome (aHUS) involves genetic defects in complement regulation.
Purpose of the Study:
- To summarize recent advancements in understanding complement dysregulation in glomerular diseases.
- To review the role of C3 and C5 in the pathogenesis of C3 glomerulopathies and aHUS.
- To discuss therapeutic strategies targeting the complement system.
Main Methods:
- Review of recent scientific literature on complement-related glomerular diseases.
- Analysis of genetic and molecular mechanisms underlying C3 glomerulopathy and aHUS.
- Evaluation of clinical data and animal models for complement-targeted therapies.
Main Results:
- C3 glomerulopathy is defined by isolated C3 deposition, with DDD and CFHR5 nephropathy as key examples.
- Systemic C3 dysregulation underlies familial DDD, while CFHR5 plays a role in kidney complement regulation.
- Animal models show C5 activation is critical in aHUS-related renal thrombotic microangiopathy and pauci-immune glomerulonephritis.
Conclusions:
- Eculizumab (anti-C5 antibody) is an effective therapy for aHUS.
- The therapeutic role of C5 inhibition in C3 glomerulopathies remains an important area for future research.
Purpose Of Review:
There is an intimate association between complement dysregulation and glomerular pathology. Here we summarise the recent progress.
Recent Findings:
C3 glomerulopathy has been introduced as a term that encompasses glomerular pathology characterised by isolated C3 deposition. The prototypic example of C3 glomerulopathy is dense deposit disease (DDD). Characterisation of a mutant C3 molecule in familial DDD has reinforced the concept that this condition results from systemic C3 dysregulation. Complement factor H-related 5 (CFHR5) nephropathy is the most recently described C3 glomerulopathy. Its characterisation supports a biological role for CFHR5 on complement regulation within the kidney. Atypical haemolytic uraemic syndrome (aHUS) is strongly associated with genetic defects in complement regulation. Animal model data indicate that the critical step in the development of renal thrombotic microangiopathy in this syndrome is activation of complement C5. Importantly, there are now many reports of the successful use of a monoclonal anti-C5 antibody therapy (eculizumab) in this syndrome and clinical trials are in progress. Intriguingly, animal model data have demonstrated a critical role for C5 activation in pauci-immune glomerulonephritis.
Summary:
C5 inhibition appears to be effective therapy for aHUS. An important unresolved question is the role of C5 inhibition in C3 glomerulopathies.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Glomerular Filtration
Components of the Filtration Membrane
The filtration process involves three key layers: the glomerular endothelial cells, the basement membrane, and the podocyte-formed filtration slits.
Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration

